Ignyta, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Dow Bounces Back From Morning Selloff
Article By: Schaeffers Research
Wednesday, December 7, 2022 12:26 PM EDT
The Dow Jones Industrial Average is trying to claw back from the market's multi-day selloff. Meanwhile, the S&P 500 Index and Nasdaq Composite Index continue to flag near breakeven.
In this article: HD, MPW, UNH, QQQ, SPX, VIX, DJI, RXDX, CVNA
Read
Foreign Stock Roundup: Roche To Buy Ignyta For $1.7B; Shell To Acquire First Utility
Article By: Swarup Gupta
Tuesday, January 2, 2018 2:50 PM EDT
Global markets traversed a holiday-shortened week marked by thin trading volumes.
In this article: BCS, PBR, RBS, NTDOY, RHHBY, RXDX
Read
Roche Deal Seen As Boon For Other Targeted Cancer Therapy Developers
Article By: The Fly
Friday, December 22, 2017 1:20 PM EDT
Roche announced a definitive agreement to fully acquire Ignyta at a price of $27 per share in an all-cash transaction valued at $1.7B on a fully diluted basis.
In this article: RHHBY Also: RXDX, LOXO, MRTX, EXEL, KPTI, SRRA
Read
Morning Call For Thursday, Oct. 19
Article By: Jim Van Meerten
Thursday, October 19, 2017 8:39 AM EDT
Dec E-mini S&Ps (ESZ17 -0.44%) this morning are down -0.51% at a 1-week low and European stocks are down -0.80% at a 2-week low as rising tensions between Spain and Catalonia spurs liquidation in equities.
In this article: GWW, NKE, S, JAZZ, LLNW, ADBE, EBAY, PEGI, EVOK, SUPN, CNAT, RXDX, ESTE
Read
Biotech Momentum Eases: September Is A Bit Sluggish
Article By: Rod Raynovich
Thursday, September 14, 2017 6:08 PM EDT
Risks for biotech stocks and the healthcare sector, in general, are with Congress: drug pricing debate and/or lack of progress on tax reform.
In this article: BLUE, XLV, IBB, ABBV, XBI, HALO, PFE, CLLS, ARRY, RXDX, KITE, AGIO, CLVS, EXEL, INCY, JUNO, TSRO, PBYI
Read
All Posts

Latest Tweets for $RXDX

No tweets yet!

PARTNER HEADLINES